CCCC
C4 Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.76
+0.53%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 20.27x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.87x
- Price / sales
- 13.20x
- Price / cash flow
- -5.45x
Enterprise value
- Enterprise value
- $265.8M
- EV / sales
- 7.58x
- EV / EBITDA
- -2.70x
- EV / EBIT
- -2.38x
- Market cap
- $462.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026